2011 Annual Report and Accounts & Notice of AGM

RNS Number : 7374R

Epistem Holdings plc

09 November 2011

 



Epistem Holdings Plc

("Epistem" or "the Company")

2011 Annual Report and Accounts & Notice of AGM

Epistem confirms that it has published its Annual Report and Accounts for the year ended 30 June 2011.  The document is available from the Company's website: www.epistem.co.uk.

Epistem confirms that its 2011 Annual General Meeting will be held at 11.00am on Wednesday, 14^th December 2011 at 48 Grafton Street, Manchester. The AGM Notice will be posted to shareholders on 22^nd November 2011.

For further information contact:

Epistem Holdings Plc

Matthew Walls, Chief Executive Officer                                               ++44 161 606 7258                                 

John Rylands, Finance Director                                                                 ++44 161 606 7244                                                        

Peel Hunt LLP

Nominated Adviser: James Steel/Vijay Barathan                              ++44 207 418 8900                                                           

Notes for editors

Epistem is a biotechnology and personalised medicine company commercialising its expertise in epithelial stem cells and pharmacogenomics in the areas of oncology, gastrointestinal, dermatological and infectious disease.

Epistem develops innovative therapeutics, biomarkers and diagnostics alongside providing preclinical services to drug development companies. Epistem's core expertise is focused on the regulation of adult stem cells located in epithelial tissue which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. Epistem has developed a range of proprietary amplification (RNA and DNA) technologies for use in drug discovery, development and diagnostics.     

 

END

 

 

MSCMMMGMLRGGMZM